Skip to content
★ Sign in to follow
SC

Sloan-Kettering Cancer Center Memorial

Shareholder
Total declarations
121
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (120 ops.)
€1.7M

Latest filing published 01 Sept 2016 for Actinium Pharmaceuticals, Inc., €38k.

Insider track record

Disclosed buys
0
Disclosed sells
120
Signal history

Sloan-Kettering Cancer Center Memorial: trading record in brief

All filings by Sloan-Kettering Cancer Center Memorial on record concern Actinium Pharmaceuticals, Inc. The record holds 121 filings, for trades running from 6 May 2015 to 31 August 2016.

Sales make up the whole of the open-market record (120 sales, €1.7M). In 2016 alone, the filings show no purchases and 120 sales.

On 1 September 2016 came the latest disclosure, an open-market sale for €38k in Actinium Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Sloan-Kettering Cancer Center Memorial

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations121 total

25 of 121 declarations